Ki-67 expression predicts locoregional recurrence in stage I oral tongue carcinoma

British Journal of Cancer

Volumn 99, Issue 7, 2008, Pages 1121-1128

  Wangsa, D ^a,b,c   Ryott, M ^a   Avall Lundqvist E ^a   Petersson, F ^a   Elmberger, G ^a   Luo, J ^c   Ried, T ^b   Auer, G ^a   Munck Wikland, E ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b NATIONAL CANCER INSTITUTE   (United States)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Genomic instability; Ki 67; Locoregional recurrence; Oral cancer; Ploidy

Indexed keywords

ANTINEOPLASTIC AGENT; KI 67 ANTIGEN; PARAFFIN;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CONTROLLED STUDY; FEMALE; GENE FUNCTION; GENOMIC INSTABILITY; HUMAN; HUMAN TISSUE; IMAGE CYTOMETRY; MALE; MOUTH CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TONGUE CARCINOMA; TUMOR BIOPSY;

ADULT; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; SURVIVAL ANALYSIS; TONGUE NEOPLASMS;

EID: 53049092877     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6604633     Document Type: Article

References (45)

1. Alvi A, Johnson JT (1996) Extracapsular spread in the clinically negative neck (N0): implications and outcome. Otolaryngol Head Neck Surg 114: 65-70
2. Annertz K, Anderson H, Biorklund A, Moller T, Kantola S, Mork J, Olsen JH, Wennerberg J (2002) Incidence and survival of squamous cell carcinoma of the tongue in Scandinavia, with special reference to young adults. Int J Cancer 101: 95-99
3. Armitage NC, Robins RA, Evans DF, Turner DR, Baldwin RW, Hardcastle JD (1985) The influence of tumour cell DNA abnormalities on survival in colorectal cancer. Br J Surg 72: 828-830
4. Baretton G, Li X, Stoll C, Fischer-Brandies E, Schmidt M, Lohrs U (1995) Prognostic significance of DNA ploidy in oral squamous cell carcinomas. A retrospective flow and image cytometric study with comparison of DNA ploidy in excisional biopsy specimens and resection specimens, primary, tumors, and lymph node metastases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 79: 68-76
5. Bilde A, von Buchwald C, Therkildsen MH, Mortensen J, Kirkegaard J, Charabi B, Specht L (2008) Need for intensive histopathologic analysis to determine lymph node metastases when using sentinel node biopsy in oral cancer. Laryngoscope 118: 408-414
6. Brenner H (2002) Long-term survival rates of cancer patients achieved by the end of the 20th century: a period analysis. Lancet 360: 1131-1135
7. Brun E, Zatterstrom U, Kjellen E, Wahlberg P, Willen R, Brun A, Perfekt R, Tennvall J (2001) Prognostic value of histopathological response to radiotherapy and microvessel density in oral squamous cell carcinomas. Acta Oncol 40: 491-496
8. Couture C, Raybaud-Diogene H, Tetu B, Bairati I, Murry D, Allard J, Fortin A (2002) p53 and Ki-67 as markers of radioresistance in head and neck carcinoma. Cancer 94: 713-722
9. Dahlgren L, Dahlstrand HM, Lindquist D, Hogmo A, Bjornestal L, Lindholm J, Lundberg B, Dalianis T, Munck-Wikland E (2004) Human papillomavirus is more common in base of tongue than in mobile tongue cancer and is a favorable prognostic factor in base of tongue cancer patients. Int J Cancer 112: 1015-1019
10. Davies L, Hardin NJ, Beatty BG (2006) Can Ki-67 predict recurrence of NO squamous cell carcinoma of the tongue? Ann Otol Rhinol Laryngol 115: 12-17
11. Ferlito A, Partridge M, Brennan J, Hamakawa H (2001) Lymph node micrometastases in head and neck cancer: a review. Acta Otolaryngol 121: 660-665
12. Ferlito A, Rinaldo A (2000) False negative conventional histology of lymph nodes in patients with head and neck cancer. ORL J Otorhinolaryngol Relat Spec 62: 112-114
13. Forastiere A, Koch W, Trotti A, Sidransky D (2001) Head and neck cancer. N Engl J Med 345: 1890-1900
14. Gonzalez-Moles MA, Caballero R, Rodriguez-Archilla A, Ruiz-Avila I, Bravo I (1996) Prognosis value of the expression of Ki-67 for squamous cell carcinoma of the oral cavity. Acta Stomatol Belg 93: 159-165
15. Grabenbauer GG, Muhlfriedel C, Rodel F, Niedobitek G, Hornung J, Rodel C, Martus P, Iro H, Kirchner T, Steininger H, Sauer R, Weidenbecher M, Distel L (2000) Squamous cell carcinoma of the oropharynx: Ki-67 and p53 can identify patients at high risk for local recurrence after surgery and postoperative radiotherapy. Int J Radiat Oncol Biol Phys 48: 1041-1050
16. Grabenbauer GG, Steininger H, Meyer M, Fietkau R, Brunner T, Heinkelmann P, Hornung J, Iro H, Spitzer W, Kirchner T, Sauer R, Distel L (1998) Nodal CT density and total tumor volume as prognostic factors after radiation therapy of stage III/IV head and neck cancer. Radiother Oncol 47: 175-183
17. Greene FL, Page DL, Fleming ID, Fritz A, Balch CM, Haller DG, Morrow M (2002) AJCC Cancer Staging Manual, 6th edn Springer: New York, NY
18. Hemmer J, Schon E, Kreidler J, Haase S (1990) Prognostic implications of DNA ploidy in squamous cell carcinomas of the tongue assessed by flow cytometry. J Cancer Res Clin Oncol 116: 83-86
19. Hogmo A, Munck-Wikland E, Kuylenstierna R, Lindholm J, Auer G (1994) Nuclear DNA content and p53 immunostaining in oral squamous cell carcinoma - an analysis of a consecutive 10-year material. Int J Oncol 5: 915-920
20. Kademani D (2007) Oral cancer. Mayo Clin Proc 82: 878-887
21. Kalnins IK, Leonard AG, Sako K, Razack MS, Shedd DP (1977) Correlation between prognosis and degree of lymph node involvement in carcinoma of the oral cavity. Am J Surg 134: 450-454
22. Kim MS, Lee SY, Cho WH, Song WS, Koh JS, Lee JA, Yoo JY, Jeon DG (2008) Initial tumor size predicts histologic response and survival in localized osteosarcoma patients. J Surg Oncol 97(5): 456-461
23. Kim SJ, Shin HJ, Jung KY, Baek SK, Shin BK, Choi J, Kim BS, Shin SW, Kim YH, Kim JS, Oosterwijk E (2007) Prognostic value of carbonic anhydrase IX and Ki-67 expression in squamous cell carcinoma of the tongue. Jpn J Clin Oncol 37: 812-819
24. Koelbl O, Rosenwald A, Haberl M, Muller J, Reuther J, Flentje M (2001) p53 and Ki-67 as predictive markers for radiosensitivity in squamous cell carcinoma of the oral cavity? An immunohistochemical and clinicopathologic study. Int J Radiat Oncol Biol Phys 49: 147-154
25. Kronenwett U, Ploner A, Zetterberg A, Bergh J, Hall P, Auer G, Pawitan Y (2006) Genomic instability and prognosis in breast carcinomas. Cancer Epidemiol Biomarkers Prev 15: 1630-1635
26. Kropveld A, Slootweg PJ, Blankenstein MA, Terhaard CH, Hordijk GJ (1998) Ki-67 and p53 in T2 laryngeal cancer. Laryngoscope 108: 1548-1552
27. Lavertu P, Adelstein DJ, Myles J, Secic M (2001) P53 and Ki-67 as outcome predictors for advanced squamous cell cancers of the head and neck treated with chemoradiotherapy. Laryngoscope 111: 1878-1892
28. Lothaire P, de Azambuja E, Dequanter D, Lalami Y, Sotiriou C, Andry G, Castro Jr G, Awada A (2006) Molecular markers of head and neck squamous cell carcinoma: promising signs in need of prospective evaluation. Head Neck 28: 256-269
29. Lydiatt DD, Robbins KT, Byers RM, Wolf PF (1993) Treatment of stage I and II oral tongue cancer. Head Neck 15: 308-312
30. Menzin J, Lines LM, Manning LN (2007) The economics of squamous cell carcinoma of the head and neck. Curr Opin Otolaryngol Head Neck Surg 15: 68-73
31. Myers JN, Elkins T, Roberts D, Byers RM (2000) Squamous cell carcinoma of the tongue in young adults: increasing incidence and factors that predict treatment outcomes. Otolaryngol Head Neck Surg 122: 44-51
32. Myoung H, Kim MJ, Lee JH, Ok YJ, Paeng JY, Yun PY (2006) Correlation of proliferative markers (Ki-67 and PCNA) with survival and lymph node metastasis in oral squamous cell carcinoma: a clinical and histopathological analysis of 113 patients. Int J Oral Maxillofac Surg 35: 1005-1010
33. Onizawa K, Yoshida H, Ohara K, Noguchi M (2006) Predictive factors for the histologic response to preoperative radiotherapy in advanced oral cancer. J Oral Maxillofac Surg 64: 81-86
34. Pich A, Chiusa L, Navone R (2004) Prognostic relevance of cell proliferation in head and neck tumors. Ann Oncol 15: 1319-1329
35. Piffko J, Bankfalvi A, Ofner D, Kusch F, Bocker W, Joos U, Schmid KW (1996) In situ assessment of cell proliferation at the invasive front of oral squamous cell carcinomas. Virchows Arch 429: 229-234
36. Raybaud-Diogene H, Fortin A, Morency R, Roy J, Monteil RA, Tetu B (1997) Markers of radioresistance in squamous cell carcinomas of the head and neck: a clinicopathologic and immunohistochemical study. J Clin Oncol 15: 1030-1038
37. Rubio Bueno P, Naval Gias L, Garcia Delgado R, Domingo Cebollada J, Diaz Gonzalez FJ (1998) Tumor DNA content as a prognostic indicator in squamous cell carcinoma of the oral cavity and tongue base. Head Neck 20: 232-239
38. Sano D, Myers JN (2007) Metastasis of squamous cell carcinoma of the oral tongue. Cancer Metastasis Rev 26: 645-662
39. Sargeran K, Murtomaa H, Safavi SM, Vehkalahti MM, Teronen O (2007) Survival after diagnosis of cancer of the oral cavity. Br J Oral Maxillofac Surg 46(3): 187-191
40. Shiboski CH, Schmidt BL, Jordan RC (2005) Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20-44 years. Cancer 103: 1843-1849
41. Steinbeck RG, Auer GU, Zetterberg AD (1999) Reliability and significance of DNA measurements in interphase nuclei and division figures in histological sections. Eur J Cancer 35: 787-795
42. Stoll C, Baretton G, Ahrens C, Lohrs U (2000) Prognostic significance of apoptosis and associated factors in oral squamous cell carcinoma. Virchows Arch 436: 102-108
43. Wilson GD, Saunders MI, Dische S, Daley FM, Buffa FM, Richman PI, Bentzen SM (2006) Pre-treatment proliferation and the outcome of conventional and accelerated radiotherapy. Eur J Cancer 42: 363-371
44. Xie X, De Angelis P, Clausen OP, Boysen M (1999) Prognostic significance of proliferative and apoptotic markers in oral tongue squamous cell carcinomas. Oral Oncol 35: 502-509
45. Yuen AP, Lam KY, Chan AC, Wei WI, Lam LK, Ho WK, Ho CM (1999) Clinicopathological analysis of elective neck dissection for N0 neck of early oral tongue carcinoma. Am J Surg 177: 90-92